The veterinary and human vaccine sections saw the introduction of "combined vaccines" monographs, allowing manufacturers greater flexibility in formulation while adhering to strict safety profiles.

For its time, Ph. Eur. 5.0 was a robust, necessary evolution , particularly in biologics and impurity control. However, its rapid supplement release schedule frustrated industry users. Today, it is obsolete ; any QC laboratory must use Ph. Eur. 11th Edition or later. Ph. Eur. 5.0 should only be consulted for historical batch documentation or legacy product licenses that were never updated.

Ph. Eur. 5.0 effectively bridged the gap between the "chemical era" of the late 20th century and the "biotech era" of the 21st century. It solidified the "Harmonised Tripartite Guidelines" into European law, making it easier for multinational companies to develop drugs for global markets. It laid the groundwork for the sophisticated risk-based approaches to quality (Q9) that would dominate later editions.